• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Netherlands·Basic Materials·MLPRX.PA
Share

Parx Materials N.V. Stocks

€ 0.48Last Updated 01.07.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

€ 5.82M

€ 0.48
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating globally, Parx Materials N.V. specializes in the development and distribution of plastics imbued with antibacterial and antimicrobial properties. These advanced materials are applied across diverse industries, such as food contact and packaging, medical devices and implants, textiles, as well as pipes and drainage systems. They also serve in anti-fouling and hygiene applications, effectively deterring mold growth, material degradation, and biofilm formation. The company employs its exclusive, patented "Saniconcentrate" technology. Established in 2012, the company was formerly known as Parx Plastics N.V., changing its name to Parx Materials N.V. in January 2020. Its main office is located in Rotterdam, the Netherlands.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.07.2026 22:40

Mizuho has added a company with 125% growth potential to its top picks. Who is the new favorite?

02.07.2026 22:08

Blue Owl reported a decline in investor requests to withdraw assets. Its stock rose

02.07.2026 21:30

Freedom expects a correction in the tech sector in July. But it won't last long.

02.07.2026 21:14

"Palantir's valuation is currently the most attractive": Analyst Predicts 39% Stock Gain

02.07.2026 19:23

Freedom Broker has removed Apple and 11 other stocks from its top picks. Who has taken their place?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026